PSA level changes over time in men with an initial PSA level of ≤4 ng/ml

被引:0
|
作者
Chris Bangma
机构
[1] Professor of Urology and the Chairman of the Department of Urology at Erasmus Medical Center,
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:520 / 521
页数:1
相关论文
共 50 条
  • [1] PSA level changes over time in men with an initial PSA level of ≤4 ng/ml -: Commentary
    Bangma, Chris
    [J]. NATURE CLINICAL PRACTICE UROLOGY, 2006, 3 (10): : 520 - 521
  • [2] Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/mL or lower
    Thompson, IM
    Ankerst, DP
    Chi, C
    Lucia, MS
    Goodman, PJ
    Crowley, JJ
    Parnes, HL
    Coltman, CA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (01): : 66 - 70
  • [3] PSA velocity in men with total PSA levels less than 4 ng/ml
    Loeb, Stacy
    Roehl, Kimberly A.
    Nadler, Robert B.
    Catalona, William J.
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 580 - 580
  • [4] The impact of PSA and digital rectal examination on the risk of prostate cancer specific mortality in men with a PSA level <2.5 ng/ml
    Pashtan, Itai
    Chen, Ming-Hui
    D'Amico, Anthony V.
    [J]. CANCER EPIDEMIOLOGY, 2014, 38 (05) : 613 - 618
  • [5] Annual PSA tests are not necessary for men with a PSA level below 2 ng/mL: Findings of the Imari prostate cancer screening program
    Uozumi, J
    Tokuda, Y
    Fujiyama, C
    Takagi, N
    Meiri, H
    Kuratomi, K
    Nakamura, K
    Ichigi, Y
    Yoshinaga, H
    Kinoshita, N
    Masaki, Z
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2002, 9 (06) : 334 - 339
  • [6] Biopsy of men with PSA level of 2.6 to 4.0 ng/ml associated with favorable pathologic features and PSA progression rate: A preliminary analysis
    Zhu, H
    Roehl, KA
    Antenor, JAV
    Catalona, WJ
    [J]. UROLOGY, 2005, 66 (03) : 547 - 551
  • [7] PSA velocity threshold for predicting prostate cancer in young men with PSA &lt; 4 ng/ml
    Loeb, S
    Roehl, KA
    Graif, T
    Viprakasit, D
    Catalona, WJ
    Nadler, RB
    [J]. JOURNAL OF UROLOGY, 2006, 175 (04): : 153 - 153
  • [8] The Clinical Importance of Percentage Free Prostate-specific Antigen (PSA) in the PSA level of 4-20 ng/ml
    Caliskan, Selahattin
    Sungur, Mustafa
    [J]. KUWAIT MEDICAL JOURNAL, 2018, 50 (03): : 316 - 319
  • [9] The likelihood of having serum level of PSA of >= 4.0 ng/mL and >= 10.0 ng/mL in non-obese and obese Nigerian men with LUTS
    Adegun, Patrick Temi
    Adebayo, Philip Babatunde
    Atiba, Samuel Adeniran
    [J]. ASIAN JOURNAL OF UROLOGY, 2015, 2 (03) : 158 - 162
  • [10] Utility of PSA doubling time (PSADT) in the detection of prostate cancer in men with a serum PSA ≤ 10 ng/ml
    Spurgeon, S
    Garzotto, M
    Collins, L
    Priest, R
    Hsieh, YC
    Peters, L
    Beer, TM
    Mori, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 414S - 414S